SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-08-000606
Filing Date
2008-01-28
Accepted
2008-01-28 16:40:02
Documents
13
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2182117z20-f.htm 20-F 3931859
2 EXHIBIT 1.2 a2182117zex-1_2.htm EX-1.2 204745
3 EXHIBIT 2.4 a2182117zex-2_4.htm EX-2.4 23352
4 EXHIBIT 4.7 a2182117zex-4_7.htm EX-4.7 1183556
5 EXHIBIT 12.1 a2182117zex-12_1.htm EX-12.1 14134
6 EXHIBIT 12.2 a2182117zex-12_2.htm EX-12.2 14126
7 EXHIBIT 13.1 a2182117zex-13_1.htm EX-13.1 7150
8 EXHIBIT 13.2 a2182117zex-13_2.htm EX-13.2 7231
9 EXHIBIT 14.1 a2182117zex-14_1.htm EX-14.1 4818
10 EX1201I001.JPG ex1201i001.jpg GRAPHIC 1366
11 EX1205I001.JPG ex1205i001.jpg GRAPHIC 1948
12 EX24I001.JPG ex24i001.jpg GRAPHIC 2395
13 G931773.JPG g931773.jpg GRAPHIC 5078
  Complete submission text file 0001047469-08-000606.txt   5407738
Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-15024 | Film No.: 08554544
SIC: 2834 Pharmaceutical Preparations